![Fergus Fleming](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 14 422 $ am 31.05.2026
Fergus Fleming is currently the Director & Chief Technology Officer at Renalytix Plc.
Previously, he worked as the Managing Director at Ff Consulting Ltd. from 2014 to 2018.
He also served as the Head-Business Development at Oncomark Ltd. from 2016 to 2018.
Mr. Fleming completed his undergraduate degree at the National University of Ireland Galway.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RENALYTIX PLC 0,14 % | 20.12.2024 | 594.481 ( 0,14 % ) | 14 422 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| RENALYTIX PLC | Technik-/Wissenschafts-/F&E-Leiter | 15.03.2018 |
| Unternehmen | Position | Ende |
|---|---|---|
Ff Consulting Ltd. | Vorstandsvorsitzender | 01.11.2018 |
Oncomark Ltd.
 Oncomark Ltd. Medical SpecialtiesHealth Technology Operates as a diagnostics company that develops novel cancer biomarkers | Corporate Officer/Principal | 01.10.2018 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
Oncomark Ltd.
Oncomark Ltd. Medical SpecialtiesHealth Technology Operates as a diagnostics company that develops novel cancer biomarkers | Health Technology |
National University of Ireland Galway
 National University of Ireland Galway Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Renalytix Plc
 Renalytix Plc Packaged SoftwareTechnology Services Provides artificial intelligence for kidney disease | Technology Services |
Ff Consulting Ltd. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
